Home
Conditions
beta-Thalassemia

Clinical trial condition

beta-Thalassemia

Explore clinical trials studying beta-Thalassemia. Study availability and eligibility vary by location and protocol.

184 public trials 29 recruiting studies

Refine in advanced search Browse all conditions

beta-Thalassemia trial results

Completed

Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major

NCT02342145

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +11 more
Locations: Liuzhou Worker's Hospital Liuzhou, Guangxi, China

The affiliated hospital of guangxi medical university Nanning, Guangxi, China

Hainan general Hospital Haikou, Hainan, China

View Trial Details

Completed

ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

NCT06831799

Conditions: Alpha-Thalassemia, Anemia, Anemia, Hemolytic, +47 more
Locations: Vall d'Hebron Institut de Recerca Barcelona, Spain

View Trial Details

Completed

Long Term Outcomes in β Thalassemia Major

NCT02307786

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study

NCT04009525

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

View Trial Details

Completed

Vitamin E Supplementation for Children With Transfusion Dependent Beta Thalassemia on Different Iron Chelation Regimen

NCT06509581

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: Ain Shams University Cairo, Abbasia, Egypt

View Trial Details

Completed

Study to Evaluate the Safety and Efficacy of Luspatercept (ACE-536) in Participants With Beta-thalassemia (A536-04/MK-6143-002)

NCT01749540

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: Laiko General Hospital, Ampelokipi Athens, Greece

Ospedale "A. Perriino" U.O Ematologia Brindisi, Italy

ARNAS Garibaldi - P.O. Garibaldi Centro Catania, Italy

A.O.U. Arcispedale S. Anna Ferrara, Italy

View Trial Details

Completed

Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (HCPs)

NCT04973280

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +10 more
Locations: Local Institutions Vienna, Austria

Local Institutions Brussels, Belgium

Local Institutions Berlin, Germany

Local Institutions Rome, Italy

View Trial Details

Completed

Fetal Haemoglobin and Cerebral and Peripheral Oxygenation.

NCT04802629

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +16 more
Locations: Department of Pediatrics, Division of Neonatology, Medical University of Graz Graz, Styria, Austria

View Trial Details

Completed

Evaluation of Low-cost Techniques for Detecting Sickle Cell Disease and β-thalassemia in Nepal and Canada

NCT05506358

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +13 more
Locations: BC Children's Hospital Vancouver, British Columbia, Canada

St. Paul's Hospital Vancouver, British Columbia, Canada

Mount Sagarmatha Polyclinic and Diagnostic Center Nepalgunj, Banke, Nepal

View Trial Details

Completed

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

NCT01931644

Conditions: ADD/ADHD, Abnormalities, Multiple, Acquired Immunodeficiency Syndrome, +282 more
Locations: Sanguine Biosciences Los Angeles, California, United States

View Trial Details

beta-Thalassemia

beta-Thalassemia trial results

Related conditions